2000 Collective Decriminalization Treatment 
The Blunt Truth
AUGUST 13, 2019
The public hearing attracted over 100 speakers and 2000 participants. The FDA is collecting data to fill these gaps. In each instance, the companies were selling products with flagrant disease-related claims that the FDA had not approved for the treatment or prevention of any ailments. What’s Next?
Cannabis Law Report
DECEMBER 27, 2021
These limited marks have created a fractured market, with little clarity for businesses in a cannabis industry that continues to grow despite the lack of federal decriminalization. Prior bills that proposed to legalize or decriminalize cannabis explicitly contemplated the use of cannabis “marks” but provided little additional guidance.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Sensi Seeds
DECEMBER 10, 2018
As a result, a new model of public health in the area of drugs has been generated, as have alternative policies at the local level in different countries to decriminalize and legalize cannabis, despite the fact that these policies do not comply with the international regulatory framework. Prohibition Does Not Stop Science.
Cannabis Law Report
JUNE 4, 2021
there has never been a better time for new treatment options. Originally a lawyer, Yang began working in startups and early stage growth companies as a founder or executive from 2000 to 2009. She is interested in the theme of ‘connectedness to Self, others, and the world’ as an important aspect of psychedelic treatment.
Kind Meds (Cannabis Education Blog)
JANUARY 27, 2023
Cannabis Measuring Points Let’s look at the way the population of the US as a collective views cannabis with a few key measuring points. Opinions have improved over time since this majority was a significant increase from the 25% support recorded in the year 2000. Possession or distribution can still lead to criminal charges.
Expert insights. Personalized for you.
80 
Let's personalize your content